Exploring barriers to the receipt of necessary medical care among cancer survivors under age 65 years

Journal of Cancer Survivorship

Volumn 12, Issue 1, 2018, Pages 28-37

  Banegas, Matthew P ^a   Dickerson, John F ^a   Kent, Erin E ^b   de Moor, Janet S ^b   Virgo, Katherine S ^c   Guy, Gery P ^d   Ekwueme, Donatus U ^d   Zheng, Zhiyuan ^e,f   Nutt, Stephanie ^g   Pace, Loyce ^h   Varga, Alexandra ^a   Waiwaiole, Lisa ^a   Schneider, Jennifer ^a   Robin Yabroff, K ⁱ  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c EMORY UNIVERSITY   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e AMERICAN CANCER SOCIETY   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^g UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^h LIVESTRONG Foundation   (United States)

ⁱ Office of the Assistant Secretary for Planning and Evaluation   (United States)

Author keywords

Access to care; financial hardship; Cancer survivors; Disparities; Medical debt

Indexed keywords

AGED; CANCER SURVIVAL; CANCER SURVIVOR; CAREGIVER; CONTROLLED STUDY; FEMALE; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICALLY UNINSURED; RISK FACTOR; TUMOR-RELATED GENE; ADOLESCENT; ADULT; ECONOMICS; HEALTH SERVICES RESEARCH; MIDDLE AGED; NEOPLASM; PATHOLOGY; QUESTIONNAIRE; STANDARDS; YOUNG ADULT;

ADOLESCENT; ADULT; CANCER SURVIVORS; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85028766193     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-017-0640-1     Document Type: Article

References (82)

1. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–89.
2. Howlader N, Noone AM, Krapacho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975–2012 Bethesda, MD: National Cancer Institute; 2015 [Available from: http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to SEER website, April 2015.
3. Institute of Medicine (IOM). Ensuring patient access to affordable cancer drugs: workshop summary. Washington, DC: The National Academies Press; 2014.
4. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103(2):117–28.
5. American Society of Clinical Oncology. The state of cancer Care in America, 2016: a report by the American Society of Clinical Oncology. J Oncol Pract. 2016;12(4):339–83.
6. Office CB. Congressional Budget Office: Insurance Coverage Provisions of the Affordable Care Act: CBO’s March 2015 Baseline Washington, D.C.: Congressional Budget Office; 2015 [Available from: https://www.cbo.gov/sites/default/files/51298-2015-03-ACA.pdf.
7. Collins SR, Rasmussen PW, Beutel S, Doty MM. The problem of underinsurance and how rising deductibles will make it worse. Findings from the Commonwealth Fund Biennial Health Insurance Survey, 2014. Issue Brief (Commonw Fund). 2015;13:1–20.
8. Kaiser Family Foundation. Health Research & Education Trust. Employer health benefits. In: Annual survey. Merlo Park: Henry J. Kaiser Family Foundation; 2015.
9. Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, et al. In support of a patient-driven initiative and petition to lower the high price of cancer drugs. Mayo Clin Proc. 2015;90(8):996–1000.
10. Yabroff KR, Dowling EC, Guy GP Jr, Banegas MP, Davidoff A, Han X, et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. 2016;34(3):259–67.
11. Banegas MP, Guy GP Jr, de Moor JS, Ekwueme DU, Virgo KS, Kent EE, et al. For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff (Millwood). 2016;35(1):54–61.
12. Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014;32(4):306–11.
13. Goldman DP, Jena AB, Lakdawalla DN, Malin JL, Malkin JD, Sun E. The value of specialty oncology drugs. Health Serv Res. 2010;45(1):115–32.
14. Kaisaeng N, Harpe SE, Carroll NV. Out-of-pocket costs and oral cancer medication discontinuation in the elderly. J Manag Care Spec Pharm. 2014;20(7):669–75.
15. Streeter SB, Schwartzberg L, Husain N, Johnsrud M. Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. J Oncol Pract. 2011;7(3 Suppl):46s–51s.
16. Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist. 2013;18(4):381–90.
17. Nipp RD, Zullig LL, Samsa G, Peppercorn JM, Schrag D, Taylor DH, Jr., et al. Identifying cancer patients who alter care or lifestyle due to treatment-related financial distress. Psychooncology. 2015;25(6):719–25.
18. Kent EE, Forsythe LP, Yabroff KR, Weaver KE, de Moor JS, Rodriguez JL, et al. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer. 2013;119(20):3710–7.
19. Weaver KE, Rowland JH, Bellizzi KM, Aziz NM. Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer. 2010;116(14):3493–504.
20. Zheng Z, Han X, Guy GP Jr, Davidoff AJ, Li C, Banegas MP, et al. Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States. Cancer. 2017;123(8):1453–63.
21. Keegan TH, Tao L, DeRouen MC, Wu XC, Prasad P, Lynch CF, et al. Medical care in adolescents and young adult cancer survivors: what are the biggest access-related barriers? J Cancer Surviv. 2014;8(2):282–92.
22. Potosky AL, Harlan LC, Albritton K, Cress RD, Friedman DL, Hamilton AS, et al. Use of appropriate initial treatment among adolescents and young adults with cancer. J Natl Cancer Inst. 2014;106(11). https://doi.org/10.1093/jnci/dju300.
23. Society AC. Cancer treatment & survivorship facts & figures 2016–2017. American Cancer Society: Atlanta; 2016.
24. Foundation L. Survivors’ experiences with employment. LIVESTRONG Foundation: Austin; 2013.
25. Foundation L. Survivors’ experience with finances and insurance. Austin: LIVESTRONG Foundation; 2014.
26. Zheng Z, Yabroff KR, Guy GP, Jr., Han X, Li C, Banegas MP, et al. Annual medical expenditure and productivity loss among colorectal, female breast, and prostate cancer survivors in the United States. J Natl Cancer Inst. 2016;108(5). https://doi.org/10.1093/jnci/djv382.
27. LIVESTRONG Foundation. LIVESTRONG Surveys. 2016. [Available from: https://www.livestrong.org/what-we-do/livestrong-surveys.
28. Yabroff KR, Dowling E, Rodriguez J, Ekwueme DU, Meissner H, Soni A, et al. The Medical Expenditure Panel Survey (MEPS) experiences with cancer survivorship supplement. J Cancer Surviv. 2012;6(4):407–19.
29. Agency for Healthcare Research and Quality. Summary of Recommendations from Round 1 Cognitive Testing of the MEPS Cancer SAQ. AHRQ, Rockville. [Available from: http://meps.ahrq.gov/mepsweb/survey_comp/hc_survey/2011/MEPS_Cancer_SAQ_R1_Results.htm.
30. Zullig LL, Peppercorn JM, Schrag D, Taylor DH, Lu Y, Samsa G. Financial distress, use of cost-coping strategies, and adherence to prescription medication among patients with cancer. J Oncol Pract. 2013;9(6 SUPPL):60s–3s.
31. Veenstra CM, Regenbogen SE, Hawley ST, Griggs JJ, Banerjee M, Kato I, et al. A composite measure of personal financial burden among patients with stage III colorectal cancer. Med Care. 2014;52(11):957–62.
32. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10.
33. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–9.
34. Kiernan M, Kraemer HC, Winkleby MA, King AC, Taylor CB. Do logistic regression and signal detection identify different subgroups at risk? Implications for the design of tailored interventions. Psychol Methods. 2001;6(1):35–48.
35. Andreescu C, Mulsant BH, Houck PR, Whyte EM, Mazumdar S, Dombrovski AY, et al. Empirically derived decision trees for the treatment of late-life depression. Am J Psychiatry. 2008;165(7):855–62.
36. Thanassi W, Noda A, Hernandez B, Newell J, Terpeluk P, Marder D, et al. Delineating a retesting zone using receiver operating characteristic analysis on serial QuantiFERON tuberculosis test results in US healthcare workers. Pulm Med. 2012;2012:291294.
37. Vuong QH. Likelihood ratio tests for model selection and non-nested hypotheses. Econometrica. 1989;57(2):307–33.
38. Kleinman LC, Norton EC. What’s the risk? A simple approach for estimating adjusted risk measures from nonlinear models including logistic regression. Health Serv Res. 2009;44(1):288–302.
39. Jagsi R, Pottow JA, Griffith KA, Bradley C, Hamilton AS, Graff J, et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol. 2014;32(12):1269–76.
40. Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol. 2012;30(14):1608–14.
41. Guy GP Jr, Yabroff KR, Ekwueme DU, Virgo KS, Han X, Banegas MP, et al. Healthcare expenditure burden among non-elderly cancer survivors, 2008-2012. Am J Prev Med. 2015;49(6 Suppl 5):S489–97.
42. Young RA, DeVoe JE. Who will have health insurance in the future? An updated projection. Ann Fam Med. 2012;10(2):156–62.
43. Shankaran V, Ramsey S. Addressing the financial burden of cancer treatment: from copay to Can't pay. JAMA Oncol. 2015;1(3):273–4.
44. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. J Am Med Assoc. 2001;285(4):421–9.
45. Hsu J, Price M, Huang J, Brand R, Fung V, Hui R, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22):2349–59.
46. Chandra A, Gruber J, McKnight R. Patient cost-sharing and hospitalization offsets in the elderly. Am Econ Rev. 2010;100(1):193–213.
47. Swartz K. Cost-sharing: Effects on spending and outcomes. The Robert Wood Johnson Foundation; 2010. http://www.rwjf.org/en/library/research/2011/12/cost-sharing--effects-onspending-and-outcomes.html.
48. Hargraves JL, Hadley J. The contribution of insurance coverage and community resources to reducing racial/ethnic disparities in access to care. Health Serv Res. 2003;38(3):809–29.
49. Shi L, Stevens GD. Vulnerability and unmet health care needs. The influence of multiple risk factors. J Gen Intern Med. 2005;20(2):148–54.
50. Donelan K, DesRoches CM, Schoen C. Inadequate health insurance: costs and consequences. Med Gen Med. 2000;2(3):E37.
51. Siminoff LA, Ross L. Access and equity to cancer care in the USA: a review and assessment. Postgrad Med J. 2005;81(961):674–9.
52. Mayberry RM, Mili F, Ofili E. Racial and ethnic differences in access to medical care. Med Care Res Rev. 2000;57(Suppl 1):108–45.
53. Office of the Assistant Secretary for Planning and Evaluation. Health insurance coverage and the affordable care act. Washington, D.C.: Office of the Assistant Secretary for Planning and Evaluation; 2015.
54. Sommers A, Cunningham PJ. Medical bill problems steady for U.S. families, 2007–2010. Track Rep. 2011;(28):1–5.
55. Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol. 2007;25(16):2270–3.
56. Armes J, Crowe M, Colbourne L, Morgan H, Murrells T, Oakley C, et al. Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009;27(36):6172–9.
57. McInnes DK, Cleary PD, Stein KD, Ding L, Mehta CC, Ayanian JZ. Perceptions of cancer-related information among cancer survivors: a report from the American Cancer Society’s studies of cancer survivors. Cancer. 2008;113(6):1471–9.
58. Beckjord EB, Arora NK, McLaughlin W, Oakley-Girvan I, Hamilton AS, Hesse BW. Health-related information needs in a large and diverse sample of adult cancer survivors: implications for cancer care. J Cancer Surviv. 2008;2(3):179–89.
59. Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112(11 Suppl):2577–92.
60. Hanratty B, Holland P, Jacoby A, Whitehead M. Financial stress and strain associated with terminal cancer—a review of the evidence. Palliat Med. 2007;21(7):595–607.
61. Harrison JD, Young JM, Price MA, Butow PN, Solomon MJ. What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer. 2009;17(8):1117–28.
62. Kim Y, Carver CS. Recognizing the value and needs of the caregiver in oncology. Curr Opin Support Palliat Care. 2012;6(2):280–8.
63. Glajchen M. The emerging role and needs of family caregivers in cancer care. J Support Oncol. 2004;2(2):145–55.
64. Zafar SY. Financial toxicity of cancer care: It’s time to intervene. J Natl Cancer Inst. 2015;109(5):djv370.
65. Advani PS, Reitzel LR, Nguyen NT, Fisher FD, Savoy EJ, Cuevas AG, et al. Financial strain and cancer risk behaviors among African Americans. Cancer Epidemiol Biomark Prev. 2014;23(6):967–75.
66. Bestvina CM, Zullig LL, Rushing C, Chino F, Samsa GP, Altomare I, et al. Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014;10(3):162–7.
67. Bona K, Dussel V, Orellana L, Kang T, Geyer R, Feudtner C, et al. Economic impact of advanced pediatric cancer on families. J Pain Symptom Manag. 2014;47(3):594–603.
68. Bradshaw M, Ellison CG. Financial hardship and psychological distress: exploring the buffering effects of religion. Soc Sci Med. 2010;71(1):196–204.
69. Davidoff AJ, Erten M, Shaffer T. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer. 2013;119(6):1257–65.
70. de Boer A, Moffatt S, Noble E, White M. Addressing the financial consequences of cancer: qualitative evaluation of a welfare rights advice service. PLoS One. 2012;7(8):e42979.
71. de Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella D, et al. The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer. 2014;120(20):3245–53.
72. Ekwueme DU, Yabroff KR, Guy GP Jr, Banegas MP, de Moor JS, Li C, et al. Medical costs and productivity losses of cancer survivors—United States, 2008-2011. MMWR Morb Mortal Wkly Rep. 2014;63(23):505–10.
73. Guy GP Jr, Ekwueme DU, Yabroff KR, Dowling EC, Li C, Rodriguez JL, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31(30):3749–57.
74. Guy GP Jr, Yabroff KR, Ekwueme DU, Smith AW, Dowling EC, Rechis R, et al. Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Aff (Millwood). 2014;33(6):1024–31.
75. Howard DH, Molinari NA, Thorpe KE. National estimates of medical costs incurred by nonelderly cancer patients. Cancer. 2004;100(5):883–91.
76. Nekhlyudov L, Walker R, Ziebell R, Rabin B, Nutt S, Chubak J. Cancer survivors’ experiences with insurance, employment and personal finances: results from a multi-site study. J Clin Oncol. 2015;33(Suppl):Abstract 9574.
77. Pisu M, Kenzik KM, Oster RA, Drentea P, Ashing KT, Fouad M, et al. Economic hardship of minority and non-minority cancer survivors 1 year after diagnosis: another long-term effect of cancer? Cancer. 2015;121(8):1257–64.
78. Ramsey S, Blough D, Kirchhoff A, Kreizenbeck K, Fedorenko C, Snell K, et al. Washington state cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood). 2013;32(6):1143–52.
79. Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors’ financial burden and quality of life: a prospective cohort study. J Oncol Pract. 2015;11(2):145–50.
80. PDQ® Adult Treatment Editorial Board. PDQ Financial Toxicity and Cancer Treatment. National Cancer Institute, Bethesda; updated 05/03/17. Available from: https://www.cancer.gov/about-cancer/managing-care/financial-toxicity-hp-pdq.
81. Hunter WG, Zhang CZ, Hesson A, Davis JK, Kirby C, Williamson LD, et al. Discuss to reduce out-of-pocket costs? Analysis of cost-saving strategies in 1,755 outpatient clinic visits. Med Decis Mak. 2016;36:900–10.
82. Liu B, Chowdhury S, De Moor J, Kent E, Machlin S, Nutt S, et al. Evaluation of Strategies to Improve Utility of Estimates From a Non-probability Based Survey. Federal Committee on Statistical Methodology Research Conference; December 1–3, 2015. https://www.westat.com/aboutus/presentations/2015-federal-committee-statistical-methodology-fcsm-statistical-policy.